Drugs / hematopoetic stem cell infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00497952 | Jul 2007 → Dec 2024 | multiple sclerosis | Talaris Therapeutics Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hematopoetic stem cell infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00497952 ↗ |
| Modality | Cell therapy | “hematopoetic stem cell infusion” NCT00497952 ↗ |